One Equity Partners (OEP) has announced it has completed a strategic investment of InfuCare Rx

InfuCare Rx, based in Fairfield, N.J., is a national provider of specialty infusion therapies and comprehensive clinical therapy management services to patients with complex conditions. Founded in 2015, the company reports servicing more than 4,000 patients across 43 states.

OEP, based in New York, is a middle market private equity firm focused on healthcare and a few other sectors in North America and Europe. Founded in 2001 and spun out of J.P. Morgan in 2015, OEP seeks control-oriented investments with flexible structure in companies with revenue between $100 million and $800 million and EBITDA of $10 million to $70 million.

Terms of the transaction were not disclosed.